Literature DB >> 22686477

Human amniotic epithelial cells are reprogrammed more efficiently by induced pluripotency than adult fibroblasts.

Charles A Easley1, Toshio Miki, Carlos A Castro, John A Ozolek, Crescenzio F Minervini, Ahmi Ben-Yehudah, Gerald P Schatten.   

Abstract

Cellular reprogramming from adult somatic cells into an embryonic cell-like state, termed induced pluripotency, has been achieved in several cell types. However, the ability to reprogram human amniotic epithelial cells (hAECs), an abundant cell source derived from discarded placental tissue, has only recently been investigated. Here we show that not only are hAECs easily reprogrammed into induced pluripotent stem cells (AE-iPSCs), but hAECs reprogram faster and more efficiently than adult and neonatal somatic dermal fibroblasts. Furthermore, AE-iPSCs express higher levels of NANOG and OCT4 compared to human foreskin fibroblast iPSCs (HFF1-iPSCs) and express decreased levels of genes associated with differentiation, including NEUROD1 and SOX17, markers of neuronal differentiation. To elucidate the mechanism behind the higher reprogramming efficiency of hAECs, we analyzed global DNA methylation, global histone acetylation, and the mitochondrial DNA A3243G point mutation. Whereas hAECs show no differences in global histone acetylation or mitochondrial point mutation accumulation compared to adult and neonatal dermal fibroblasts, hAECs demonstrate a decreased global DNA methylation compared to dermal fibroblasts. Likewise, quantitative gene expression analyses show that hAECs endogenously express OCT4, SOX2, KLF4, and c-MYC, all four factors used in cellular reprogramming. Thus, hAECs represent an ideal cell type for testing novel approaches for generating clinically viable iPSCs and offer significant advantages over postnatal cells that more likely may be contaminated by environmental exposures and infectious agents.

Entities:  

Mesh:

Year:  2012        PMID: 22686477      PMCID: PMC4361010          DOI: 10.1089/cell.2011.0106

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  45 in total

1.  HLA-haplotype banking and iPS cells.

Authors:  Norio Nakatsuji; Fumiaki Nakajima; Katsushi Tokunaga
Journal:  Nat Biotechnol       Date:  2008-07       Impact factor: 54.908

2.  Isolation of amniotic epithelial stem cells.

Authors:  Toshio Miki; Fabio Marongiu; Kenneth Dorko; Ewa C S Ellis; Stephen C Strom
Journal:  Curr Protoc Stem Cell Biol       Date:  2010-01

3.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

4.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

7.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

8.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.

Authors:  Chunliang Li; Junmei Zhou; Guilai Shi; Yu Ma; Ying Yang; Junjie Gu; Hongyao Yu; Shibo Jin; Zhe Wei; Fang Chen; Ying Jin
Journal:  Hum Mol Genet       Date:  2009-08-13       Impact factor: 6.150

10.  Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching.

Authors:  Craig J Taylor; Eleanor M Bolton; Susan Pocock; Linda D Sharples; Roger A Pedersen; J Andrew Bradley
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  13 in total

1.  Characterization of amniotic stem cells.

Authors:  Chika Koike; Kaixuan Zhou; Yuji Takeda; Moustafa Fathy; Motonori Okabe; Toshiko Yoshida; Yukio Nakamura; Yukio Kato; Toshio Nikaido
Journal:  Cell Reprogram       Date:  2014-08       Impact factor: 1.987

Review 2.  Gamete derivation from embryonic stem cells, induced pluripotent stem cells or somatic cell nuclear transfer-derived embryonic stem cells: state of the art.

Authors:  Charles A Easley; Calvin R Simerly; Gerald Schatten
Journal:  Reprod Fertil Dev       Date:  2014-12       Impact factor: 2.311

Review 3.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

4.  Direct differentiation of human pluripotent stem cells into haploid spermatogenic cells.

Authors:  Charles A Easley; Bart T Phillips; Megan M McGuire; Jennifer M Barringer; Hanna Valli; Brian P Hermann; Calvin R Simerly; Aleksander Rajkovic; Toshio Miki; Kyle E Orwig; Gerald P Schatten
Journal:  Cell Rep       Date:  2012-08-23       Impact factor: 9.423

Review 5.  A Rational Strategy for the Use of Amniotic Epithelial Stem Cell Therapy for Liver Diseases.

Authors:  Toshio Miki
Journal:  Stem Cells Transl Med       Date:  2016-03-03       Impact factor: 6.940

6.  The N-ethylmaleimide-sensitive factor and dysbindin interact to modulate synaptic plasticity.

Authors:  Avanti Gokhale; Ariana P Mullin; Stephanie A Zlatic; Charles A Easley; Megan E Merritt; Nisha Raj; Jennifer Larimore; David E Gordon; Andrew A Peden; Subhabrata Sanyal; Victor Faundez
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

7.  Gestational stage affects amniotic epithelial cells phenotype, methylation status, immunomodulatory and stemness properties.

Authors:  Barbara Barboni; Valentina Russo; Valentina Curini; Alessandra Martelli; Paolo Berardinelli; Annunziata Mauro; Mauro Mattioli; Marco Marchisio; Patrizia Bonassi Signoroni; Ornella Parolini; Alessia Colosimo
Journal:  Stem Cell Rev Rep       Date:  2014-10       Impact factor: 5.739

8.  In vitro generation of Sertoli-like and haploid spermatid-like cells from human umbilical cord perivascular cells.

Authors:  Ekaterina Shlush; Leila Maghen; Sonja Swanson; Shlomit Kenigsberg; Sergey Moskovtsev; Tanya Barretto; Andrée Gauthier-Fisher; Clifford L Librach
Journal:  Stem Cell Res Ther       Date:  2017-02-15       Impact factor: 6.832

9.  Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations.

Authors:  Gareth D Greggains; Lisa M Lister; Helen A L Tuppen; Qi Zhang; Louise H Needham; Nilendran Prathalingam; Louise A Hyslop; Lyndsey Craven; Zbigniew Polanski; Alison P Murdoch; Douglass M Turnbull; Mary Herbert
Journal:  Sci Rep       Date:  2014-01-24       Impact factor: 4.379

10.  Genome-wide analysis reveals the unique stem cell identity of human amniocytes.

Authors:  Colin T Maguire; Bradley L Demarest; Jonathon T Hill; James D Palmer; Arthur R Brothman; H Joseph Yost; Maureen L Condic
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.